REFERENCE
EBITDA multiples in home care, home health, and hospice
An EBITDA multiple is simply the price a buyer pays divided by adjusted annual earnings. In home care, home health, and hospice, the multiple a specific agency earns depends far more on size, payer quality, and owner dependence than on the segment average. Anyone who quotes you a single number without seeing your financials is guessing.
By Akim Guennani, Founder · Updated September 2026
8.5x
2025 healthcare services average EV / EBITDA
6.0x
2025 average for $10M to $25M enterprise values
229
US mid-market healthcare deals in Q4 2025
Why size moves the multiple so much
Buyers price risk. An agency with a few hundred thousand dollars of EBITDA is usually one owner, a handful of referral relationships, and limited infrastructure, so a departure or a rate change is material. A platform with several million dollars of EBITDA has management depth, multiple sites, and diversified payers, so the same shock is absorbed.
This is why consolidation works, and why rollover equity is attractive: an owner who rolls a stake into a larger platform can see that stake revalued at the platform multiple in the next transaction.
What pulls an agency into a higher band
These are the changes that most reliably improve the multiple, and most can be started a year before any sale.
- Management depth
- A director who runs operations without you makes the business transferable.
- Payer and referral diversification
- No single source above roughly 20 to 25 percent of revenue.
- Clean financial reporting
- Accrual accounting, monthly close, and a defensible EBITDA adjustment schedule.
- Documented compliance
- Current licenses, accreditation, exclusion screening, and clean survey history.
- Demonstrated growth
- Census, admissions, or visit growth over the trailing two years.
What a multiple does not tell you
A high multiple attached to a large earnout, a long commitment period, and a punishing working capital peg can be worth less than a lower multiple paid mostly in cash. Compare total expected proceeds, the probability of each contingent component, and what your life looks like after closing.
What EBITDA multiples represent
An EBITDA multiple is a shorthand way to describe the value of a business relative to its annual cash flow. Across all healthcare services transactions, MNP reported an average EV/EBITDA multiple of 8.5x in 2025. In the lower mid-market ($10 million to $25 million of enterprise value) the average was 6.0x, down from 6.8x in 2024. This number represents the 'Enterprise Value' divided by the 'Adjusted EBITDA.' It is a reflection of the market's perception of risk and growth potential. Higher multiples are paid for businesses with stable earnings, low risk, and high growth prospects.
For home care agencies, the bands in the table below follow Scope Research's 2025 ranges for personal care and home health and 2026 industry benchmarks for hospice; the next section breaks them out by segment. It is dangerous to assume any average applies to a specific business. A single-location agency and a large, multi-state platform have different scale, liquidity, management, and risk profiles. The multiple is not a static fact; it is a negotiated figure that depends on dozens of variables, including compliance, payer mix, and the current interest rate environment.
| Range | Typical home care multiple | Business Characteristics | Market Perception |
|---|---|---|---|
| Lower Range | 3x to 5x EBITDA | High turnover, single site, owner-dependent | Higher Risk / Lower Growth |
| Middle Range | 5x to 8x EBITDA | Stable staff, multi-site, professional management | Moderate Risk / Standard Growth |
| Upper Range | 8x to 12x+ EBITDA | Multi-state, diversified payers, strong margins | Lower Risk / High Growth |
| Public Market | Not comparable | Massive scale, highly liquid (e.g. Addus HomeCare) | Non-Comparable to Private |
Published multiple ranges by segment and size
Published EBITDA multiple bands for home care, by segment and size. Personal care and home health follow Scope Research's 2025 review of home-based care deals. Personal care (non-medical) agencies trade at about 3x to 5x when small and single-market, 5x to 8x for regional operators, and 7x to 10x for scaled platforms. Medicare-certified home health trades at about 3x to 6x under roughly $5 million of revenue, 6x to 9x for regional multi-branch agencies ($5 million to $25 million of revenue), and 9x to 12x or more for multi-state platforms.
Hospice, per 2026 industry benchmarks, trades at about 4.5x to 6x below $500,000 of EBITDA, 5.5x to 7.5x between $500,000 and $2 million, and 7x to 9x above $2 million. For the smallest deals, Scope's database puts the median at 4.7x EBITDA for home-based care transactions under $10 million of enterprise value, with the middle half between 4.1x and 6.5x. Skilled home health generally prices above personal care at the same EBITDA because the Medicare certification and episodic revenue carry more strategic value.
| Segment | Small, single market | Regional / mid-size | Large platform |
|---|---|---|---|
| Personal care (non-medical) | 3x to 5x | 5x to 8x | 7x to 10x |
| Home health (Medicare-certified) | 3x to 6x | 6x to 9x | 9x to 12x+ |
| Hospice | 4.5x to 6x | 5.5x to 7.5x | 7x to 9x |
Adjusting EBITDA for a sale
Most private businesses are managed to minimize taxes, not maximize profit. Before a sale, you must 'normalize' or 'adjust' your EBITDA to show the true earning power of the business. Common adjustments include adding back personal expenses, one-time legal fees, and the portion of the owner's salary that exceeds a market-rate replacement. Without these adjustments, your business will appear less profitable and command a lower valuation.
Buyers will perform their own 'Quality of Earnings' (QofE) analysis to verify these adjustments. They will look for 'debt-like items' such as unfunded PTO or pending legal settlements that could reduce the final price. Public home care companies such as Addus HomeCare operate at a different scale, with cheaper capital and diversified payers, so their trading multiples should not be used as a direct benchmark for a private agency.
Illustrative example: Impact of a Multiple Shift
If an agency has $500,000 in Adjusted EBITDA, a 5x multiple results in a $2.5M value. If the owner improves caregiver retention and diversifies the payer mix, they might earn a 7x multiple. At the same $500,000 EBITDA, the value rises to $3.5M. This $1,000,000 increase in value comes from reducing risk, not necessarily from increasing current earnings.
The role of market conditions
External factors like interest rates and federal policy also affect multiples. When debt is expensive, buyers cannot pay as much for acquisitions because their financing costs are higher. Furthermore, increased regulatory scrutiny, such as the March 2024 federal inquiry into private equity in healthcare, can lead to more cautious bidding. Sellers should be aware that the 'market multiple' can shift quickly based on factors outside their control.
Preparation is the best way to protect your multiple. Having clean, audited financials and a strong management team makes your business a 'flight to quality' asset that can command top dollar even in a difficult market. Always seek specialized financial and legal advice before entering into a transaction, as deal structures and tax implications are complex and varies by situation. This guide is for general informational purposes only.
Sources and methodology
Public transactions provide market context, not a valuation quote for a private practice. Illustrative examples use hypothetical assumptions and are not predictions. This guide is educational and is not legal, tax, accounting, or investment advice.
- 1. Healthcare Services Quarterly Update, Q4 2025 (MNP). 8.5x average healthcare services EV/EBITDA in 2025; 6.0x for $10M to $25M deals (6.8x in 2024).
- 2. Home Health Valuation Multiples and M&A Trends 2025 (Scope Research). EBITDA multiple ranges by segment and size for personal care and home health.
- 3. Valuation Multiples from Small Home Health and Hospice M&A Transactions (Scope Research). 4.7x median EBITDA multiple (4.1x to 6.5x interquartile) for home-based deals under $10M EV.
- 4. FTC PE in Healthcare Workshop (FTC). Reference for the March 2024 government inquiry into healthcare ownership.
Reviewed September 2026
Questions owners ask
Straight answers, before you commit to anything.
What multiple will my agency get?+
Most independent agencies fall in published small-agency bands: about 3x to 5x adjusted EBITDA for personal care and 3x to 6x for Medicare-certified home health, with a 4.7x median for home-based care deals under $10 million of enterprise value (Scope Research). Where you land depends on your adjusted EBITDA, payer mix, and concentration profile, which is why we show you what actual buyers in our network say.
Do multiples change with interest rates?+
Yes. Acquisition financing costs affect what buyers can pay, particularly for leveraged platform deals. Demand for home care assets has remained strong across rate cycles because the underlying need keeps growing.
Is a strategic buyer always better than private equity?+
Not always. Strategics can pay for synergies but may absorb your brand and staff. Financial buyers often preserve the team and offer rollover equity. The right answer depends on what you want after closing.
Related resources
Home care
Deal structure
- How to compare offers for your agency
- Letters of intent, clause by clause
- What a buyer's expression of interest means
- Types of acquisitions
- Rollover equity explained
- Healthcare business broker vs. buy-side introductions
- How selling works
- Asset sale vs. stock sale for healthcare practices
- Quality of earnings reports
- How earnouts work and how often they pay
- Escrow and holdbacks
Keep reading
Home care valuation
How home care and home health agencies are valued: adjusted EBITDA, general market multiple ranges, and the factors that move your number up or down.
Who buys agencies
Who acquires home care, home health, and hospice agencies in the US: private equity platforms, strategics, family offices, and local operators.
Types of acquisitions
The deal structures available to home care agency owners: full sale, recapitalization, growth partnership, and how rollover equity creates a second payday.
Confidential inquiry
Tell us about your agency.
Everything you send stays between us. We never list or shop an agency, and nothing goes to a buyer without your explicit approval. There is no cost to you at any stage.